Deutsche Bank’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$522K Buy
21,136
+2,887
+16% +$50.5K ﹤0.01% 2551
2025
Q4
$309K Buy
18,249
+850
+5% +$15K ﹤0.01% 2816
2025
Q3
$378K Hold
17,399
﹤0.01% 2696
2025
Q2
$248K Buy
+17,399
New +$275K ﹤0.01% 2848
2021
Q2
Sell
-11,872
Closed -$87K 4653
2021
Q1
$87K Sell
11,872
-1,222
-9% -$10.4K ﹤0.01% 4054
2020
Q4
$106K Buy
13,094
+4,479
+52% +$34.6K ﹤0.01% 3816
2020
Q3
$68K Buy
8,615
+1,829
+27% +$12.5K ﹤0.01% 3728
2020
Q2
$37K Buy
+6,786
New +$33.7K ﹤0.01% 3933
2019
Q2
Sell
-1,621
Closed -$12K 5339
2019
Q1
$12K Buy
1,621
+1,321
+440% +$9.18K ﹤0.01% 4879
2018
Q4
$1K Buy
+300
New +$1.84K ﹤0.01% 5096

Other funds holding ETON

Deutsche Bank's ETON Position: Q1 2026 in Review

Deutsche Bank increased its Eton Pharmaceutcials (ETON) stake by 16% in Q1 2026, buying an estimated $50.5K and bringing the position to 21,136 shares worth $522K. The position accounts for ﹤0.01% of the portfolio, ranked #2551.

Deutsche Bank first reported a position in ETON in Q4 2018 and has held it in 10 quarters since. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Deutsche Bank held 21,136 shares of Eton Pharmaceutcials worth $522K as of Q1 2026.
  • Deutsche Bank bought 2,887 Eton Pharmaceutcials shares in Q1 2026, an estimated $50.5K.
  • Eton Pharmaceutcials made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #2551 holding.
  • Deutsche Bank first reported a position in Eton Pharmaceutcials in Q4 2018 and has held it in 10 quarters since.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.